Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
GRNLSA.p53_damage: Meta traits — page 6
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 297 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 5,001–5,288 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 5001 | MYOC/NOTCH3 ratio | PRORT001566 | 4.42e-05 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 5002 | Membranous nephropathy | NEPHR000008 | 4.42e-05 | Nephrourologic | Myeloid | 15 | 7 | 16 | 25 | |
| 5003 | PRKG1 levels | PROLV001633 | 4.41e-05 | Protein levels | Stromal / connective | 10 | 4 | 7 | 15 | |
| 5004 | S100A16 levels | PROLV001770 | 4.41e-05 | Protein levels | Vascular | 10 | 0 | 4 | 9 | |
| 5005 | EDAR/SPARC ratio | PRORT000979 | 4.41e-05 | Protein ratios | Platelet | 7 | 3 | 9 | 17 | |
| 5006 | Food-related dermatitis | DERMA000011 | 4.38e-05 | Dermatologic | Lymphocyte | 0 | 0 | 9 | 19 | |
| 5007 | HBEGF/LAT2 ratio | PRORT001267 | 4.34e-05 | Protein ratios | Myeloid | 14 | 3 | 12 | 22 | |
| 5008 | TSHB levels | PROLV002114 | 4.18e-05 | Protein levels | Renal epithelium | 34 | 0 | 8 | 4 | |
| 5009 | PDCD1/TNFRSF8 ratio | PRORT001630 | 4.14e-05 | Protein ratios | B / plasma cell | 33 | 3 | 17 | 35 | |
| 5010 | FCRL5/LY96 ratio | PRORT001134 | 4.13e-05 | Protein ratios | B / plasma cell | 39 | 5 | 15 | 23 | |
| 5011 | ABL1/DNMBP ratio | PRORT000009 | 4.12e-05 | Protein ratios | Hepatocyte | 1 | 1 | 9 | 21 | |
| 5012 | Drug poisoning | MISCL000036 | 4.11e-05 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 5013 | MYBPC1 levels | PROLV001356 | 4.08e-05 | Protein levels | Muscle / cardiac | 18 | 4 | 9 | 21 | |
| 5014 | VSIG4 levels | PROLV002171 | 3.99e-05 | Protein levels | Myeloid | 35 | 2 | 7 | 10 | |
| 5015 | NID1/TIMP3 ratio | PRORT001590 | 3.96e-05 | Protein ratios | Vascular | 24 | 1 | 7 | 11 | |
| 5016 | CTSZ levels | PROLV000570 | 3.96e-05 | Protein levels | Hepatocyte | 81 | 1 | 7 | 12 | |
| 5017 | EDAR/ENO2 ratio | PRORT000966 | 3.94e-05 | Protein ratios | Myeloid | 31 | 4 | 7 | 19 | |
| 5018 | OCLN levels | PROLV001461 | 3.93e-05 | Protein levels | Lymphocyte | 0 | 3 | 6 | 39 | |
| 5019 | EDAR/PRDX5 ratio | PRORT000974 | 3.88e-05 | Protein ratios | Myeloid | 42 | 2 | 10 | 16 | |
| 5020 | PDGFA/PLA2G4A ratio | PRORT001632 | 3.87e-05 | Protein ratios | Myeloid | 11 | 3 | 8 | 12 | |
| 5021 | FOXO1/IRAK4 ratio | PRORT001172 | 3.80e-05 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 29 | |
| 5022 | CHAC2 levels | PROLV000422 | 3.77e-05 | Protein levels | Vascular | 4 | 3 | 10 | 21 | |
| 5023 | CDH15 levels | PROLV000372 | 3.77e-05 | Protein levels | Hepatocyte | 22 | 2 | 5 | 12 | |
| 5024 | SKAP2 levels | PROLV001873 | 3.76e-05 | Protein levels | Myeloid | 27 | 2 | 7 | 22 | |
| 5025 | FASLG levels | PROLV000771 | 3.72e-05 | Protein levels | Myeloid | 149 | 2 | 14 | 29 | |
| 5026 | Epicondylitis | MSKEL000062 | 3.70e-05 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 18 | |
| 5027 | IL15/KLRD1 ratio | PRORT001343 | 3.68e-05 | Protein ratios | Myeloid | 41 | 4 | 12 | 23 | |
| 5028 | EFNA4/TNFRSF10B ratio | PRORT000991 | 3.63e-05 | Protein ratios | Vascular | 0 | 2 | 7 | 23 | |
| 5029 | FCRL2 levels | PROLV000784 | 3.63e-05 | Protein levels | B / plasma cell | 91 | 1 | 4 | 7 | |
| 5030 | FOLR2/HAVCR2 ratio | PRORT001168 | 3.57e-05 | Protein ratios | Myeloid | 79 | 5 | 20 | 28 | |
| 5031 | INPP1/NT5C3A ratio | PRORT001359 | 3.57e-05 | Protein ratios | Hepatocyte | 1 | 4 | 9 | 22 | |
| 5032 | BST2/MME ratio | PRORT000254 | 3.51e-05 | Protein ratios | Renal epithelium | 5 | 0 | 6 | 12 | |
| 5033 | CD160/NCR1 ratio | PRORT000378 | 3.38e-05 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 5034 | BECN1 levels | PROLV000192 | 3.36e-05 | Protein levels | Muscle / cardiac | 30 | 4 | 7 | 17 | |
| 5035 | GZMB/IL15 ratio | PRORT001263 | 3.31e-05 | Protein ratios | Lymphocyte | 36 | 2 | 13 | 20 | |
| 5036 | PFKM levels | PROLV001541 | 3.29e-05 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 5037 | MUC2 levels | PROLV001353 | 3.26e-05 | Protein levels | B / plasma cell | 35 | 0 | 6 | 8 | |
| 5038 | FHIT/GLOD4 ratio | PRORT001144 | 3.22e-05 | Protein ratios | Lymphocyte | 0 | 1 | 6 | 29 | |
| 5039 | Gut microbial abundance, Olsenella C | GASTR000030 | 3.22e-05 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 5040 | SPON2 levels | PROLV001937 | 3.22e-05 | Protein levels | Hepatocyte | 44 | 4 | 9 | 17 | |
| 5041 | RHOC/TBCC ratio | PRORT001741 | 3.17e-05 | Protein ratios | Myeloid | 0 | 4 | 10 | 12 | |
| 5042 | IL12RB1 levels | PROLV001046 | 3.15e-05 | Protein levels | Muscle / cardiac | 54 | 5 | 14 | 18 | |
| 5043 | CLEC4G/LGALS4 ratio | PRORT000660 | 3.13e-05 | Protein ratios | Myeloid | 26 | 2 | 10 | 19 | |
| 5044 | Middle ear and mastoid disorder | AUDIO000016 | 3.12e-05 | Auditory | B / plasma cell | 51 | 4 | 14 | 30 | |
| 5045 | CCL5/TACC3 ratio | PRORT000359 | 3.09e-05 | Protein ratios | Myeloid | 3 | 7 | 17 | 29 | |
| 5046 | CNST/ITGB1BP2 ratio | PRORT000683 | 3.02e-05 | Protein ratios | Muscle / cardiac | 8 | 3 | 11 | 19 | |
| 5047 | ICAM3 levels | PROLV001006 | 3.01e-05 | Protein levels | B / plasma cell | 143 | 2 | 12 | 18 | |
| 5048 | ITGB1BP2/TIA1 ratio | PRORT001389 | 2.99e-05 | Protein ratios | Lymphocyte | 21 | 4 | 12 | 27 | |
| 5049 | ASS1 levels | PROLV000156 | 2.87e-05 | Protein levels | Hepatocyte | 31 | 2 | 11 | 15 | |
| 5050 | SCG2 levels | PROLV001784 | 2.87e-05 | Protein levels | Hepatocyte | 20 | 1 | 7 | 11 | |
| 5051 | SKAP1 levels | PROLV001872 | 2.81e-05 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 5052 | Viral intestinal infection | IMMUN000077 | 2.80e-05 | Immunologic | Hepatocyte | 3 | 1 | 5 | 11 | |
| 5053 | FADD/NFATC1 ratio | PRORT001107 | 2.75e-05 | Protein ratios | Hepatocyte | 4 | 1 | 9 | 16 | |
| 5054 | ATP5IF1/HSPA1A ratio | PRORT000158 | 2.73e-05 | Protein ratios | Myeloid | 21 | 3 | 7 | 15 | |
| 5055 | KIR3DL1 levels | PROLV001143 | 2.69e-05 | Protein levels | Lymphocyte | 97 | 3 | 13 | 37 | |
| 5056 | FYB1/PDGFB ratio | PRORT001198 | 2.68e-05 | Protein ratios | Myeloid | 10 | 3 | 12 | 20 | |
| 5057 | REG4 levels | PROLV001720 | 2.68e-05 | Protein levels | Pancreatic epithelium | 61 | 0 | 6 | 9 | |
| 5058 | NAP1L4 levels | PROLV001374 | 2.66e-05 | Protein levels | Lymphocyte | 15 | 3 | 9 | 33 | |
| 5059 | Heme malignancy, Leukaemia | MALIG000042 | 2.65e-05 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 5060 | CRKL/DBNL ratio | PRORT000762 | 2.58e-05 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 23 | |
| 5061 | DBI/EDAR ratio | PRORT000861 | 2.57e-05 | Protein ratios | Myeloid | 37 | 3 | 6 | 16 | |
| 5062 | CD160/KLRB1 ratio | PRORT000377 | 2.50e-05 | Protein ratios | Lymphocyte | 2 | 2 | 13 | 20 | |
| 5063 | CAPS levels | PROLV000264 | 2.48e-05 | Protein levels | Hematopoietic progenitor | 43 | 2 | 5 | 11 | |
| 5064 | FABP1 levels | PROLV000751 | 2.42e-05 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 5065 | LY6D/WFDC12 ratio | PRORT001470 | 2.39e-05 | Protein ratios | Myeloid | 14 | 2 | 17 | 20 | |
| 5066 | Hypothyroidism, autoimmune | IMMUN000015 | 2.37e-05 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 5067 | PGR levels | PROLV001548 | 2.34e-05 | Protein levels | B / plasma cell | 21 | 3 | 12 | 30 | |
| 5068 | PATE4 levels | PROLV001498 | 2.34e-05 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 5069 | C9 levels | PROLV000238 | 2.34e-05 | Protein levels | Hepatocyte | 88 | 3 | 12 | 21 | |
| 5070 | Optic cup area | OPHTH000028 | 2.31e-05 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 5071 | FUT3 levels | PROLV000837 | 2.29e-05 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 5072 | Glycosylceramides | LIPID000069 | 2.23e-05 | Lipids | Myeloid | 1 | 1 | 9 | 16 | |
| 5073 | DAG1/GP6 ratio | PRORT000847 | 2.22e-05 | Protein ratios | Myeloid | 1 | 2 | 7 | 11 | |
| 5074 | CCL18/RARRES2 ratio | PRORT000348 | 2.11e-05 | Protein ratios | Myeloid | 8 | 2 | 10 | 15 | |
| 5075 | GUSB levels | PROLV000946 | 2.08e-05 | Protein levels | Hepatocyte | 109 | 2 | 9 | 12 | |
| 5076 | IBD-Ulcerative colitis, with PSC | IMMUN000016 | 2.07e-05 | Immunologic | Myeloid | 38 | 5 | 13 | 25 | |
| 5077 | TIRAP levels | PROLV002042 | 2.06e-05 | Protein levels | Hepatocyte | 1 | 2 | 7 | 14 | |
| 5078 | PIK3AP1/PSMG3 ratio | PRORT001664 | 2.04e-05 | Protein ratios | Lymphocyte | 1 | 1 | 6 | 9 | |
| 5079 | PPME1 levels | PROLV001612 | 2.02e-05 | Protein levels | Vascular | 9 | 4 | 12 | 31 | |
| 5080 | FABP4/SNCG ratio | PRORT001101 | 1.97e-05 | Protein ratios | Myeloid | 1 | 2 | 4 | 6 | |
| 5081 | YOD1 levels | PROLV002206 | 1.93e-05 | Protein levels | Lymphocyte | 0 | 4 | 12 | 40 | |
| 5082 | DKK1/PDGFA ratio | PRORT000898 | 1.93e-05 | Protein ratios | Hematopoietic progenitor | 4 | 3 | 10 | 26 | |
| 5083 | CIAPIN1/SPARC ratio | PRORT000618 | 1.86e-05 | Protein ratios | Myeloid | 9 | 1 | 8 | 13 | |
| 5084 | CA2/CA3 ratio | PRORT000274 | 1.86e-05 | Protein ratios | Muscle / cardiac | 0 | 3 | 11 | 23 | |
| 5085 | MED18/TACC3 ratio | PRORT001510 | 1.76e-05 | Protein ratios | Lymphocyte | 0 | 4 | 8 | 24 | |
| 5086 | Pregnancy complication, haemorrhage | REPRO000030 | 1.67e-05 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 5087 | EDAR/IRAK4 ratio | PRORT000971 | 1.67e-05 | Protein ratios | Myeloid | 38 | 2 | 13 | 16 | |
| 5088 | PDGFA/SNAP23 ratio | PRORT001636 | 1.64e-05 | Protein ratios | Myeloid | 9 | 2 | 15 | 16 | |
| 5089 | Female genital disorder | REPRO000006 | 1.63e-05 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 5090 | RGMA/RGMB ratio | PRORT001736 | 1.62e-05 | Protein ratios | Muscle / cardiac | 14 | 1 | 5 | 12 | |
| 5091 | Dentures | DENTA000006 | 1.57e-05 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 5092 | RNF5 levels | PROLV001748 | 1.52e-05 | Protein levels | Myeloid | 29 | 1 | 4 | 9 | |
| 5093 | Heart disease | CARDI000036 | 1.50e-05 | Cardiac | Muscle / cardiac | 66 | 4 | 8 | 25 | |
| 5094 | CA5A/KRT18 ratio | PRORT000288 | 1.44e-05 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 19 | |
| 5095 | CCN2/SERPINB1 ratio | PRORT000367 | 1.44e-05 | Protein ratios | Myeloid | 9 | 2 | 8 | 10 | |
| 5096 | GP2/LGALS4 ratio | PRORT001229 | 1.43e-05 | Protein ratios | Pancreatic epithelium | 36 | 0 | 3 | 4 | |
| 5097 | CASP3/PDGFB ratio | PRORT000317 | 1.39e-05 | Protein ratios | Myeloid | 3 | 4 | 10 | 18 | |
| 5098 | MEP1A levels | PROLV001297 | 1.39e-05 | Protein levels | Hepatocyte | 100 | 1 | 7 | 11 | |
| 5099 | ATP5IF1/FXN ratio | PRORT000157 | 1.39e-05 | Protein ratios | Hepatocyte | 7 | 4 | 12 | 21 | |
| 5100 | Frailty, disability | MISCL000038 | 1.37e-05 | Miscellaneous | Neural / glial | 3 | 3 | 10 | 4 | |
| 5101 | APOL1 levels | PROLV000127 | 1.37e-05 | Protein levels | Hepatocyte | 130 | 1 | 7 | 6 | |
| 5102 | DYNLT1 levels | PROLV000667 | 1.36e-05 | Protein levels | Myeloid | 7 | 1 | 8 | 11 | |
| 5103 | IRAK1/NFATC1 ratio | PRORT001368 | 1.34e-05 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 22 | |
| 5104 | PLA2G15 levels | PROLV001566 | 1.33e-05 | Protein levels | Myeloid | 214 | 2 | 9 | 10 | |
| 5105 | COMT levels | PROLV000497 | 1.30e-05 | Protein levels | Vascular | 9 | 6 | 11 | 23 | |
| 5106 | SCN4B levels | PROLV001791 | 1.30e-05 | Protein levels | Myeloid | 54 | 1 | 6 | 12 | |
| 5107 | GBP1 levels | PROLV000860 | 1.28e-05 | Protein levels | Lymphocyte | 24 | 2 | 13 | 40 | |
| 5108 | CASP3/PDGFA ratio | PRORT000316 | 1.28e-05 | Protein ratios | Myeloid | 9 | 4 | 11 | 16 | |
| 5109 | CDKN2D/MANF ratio | PRORT000579 | 1.24e-05 | Protein ratios | Platelet | 12 | 3 | 5 | 11 | |
| 5110 | F2R/SPINT2 ratio | PRORT001083 | 1.21e-05 | Protein ratios | Muscle / cardiac | 13 | 4 | 13 | 28 | |
| 5111 | Cancer, Respiratory system | MALIG000027 | 1.21e-05 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 5112 | FCRL6/KLRD1 ratio | PRORT001138 | 1.20e-05 | Protein ratios | Lymphocyte | 19 | 5 | 13 | 39 | |
| 5113 | GLOD4/S100A4 ratio | PRORT001220 | 1.19e-05 | Protein ratios | Epithelial | 8 | 0 | 9 | 9 | |
| 5114 | Erythematosquamous dermatosis | DERMA000009 | 1.19e-05 | Dermatologic | Lymphocyte | 92 | 2 | 19 | 20 | |
| 5115 | SERPINE2 levels | PROLV001831 | 1.15e-05 | Protein levels | Myeloid | 49 | 4 | 8 | 13 | |
| 5116 | CCL18 levels | PROLV000284 | 1.14e-05 | Protein levels | Myeloid | 16 | 3 | 9 | 15 | |
| 5117 | HAVCR2/TNFRSF1B ratio | PRORT001265 | 1.13e-05 | Protein ratios | Myeloid | 80 | 2 | 12 | 16 | |
| 5118 | EDAR/SNAP23 ratio | PRORT000978 | 1.12e-05 | Protein ratios | Myeloid | 33 | 3 | 15 | 20 | |
| 5119 | Cardiovascular disease, none | CARDI000034 | 1.09e-05 | Cardiac | Vascular | 201 | 2 | 5 | 9 | |
| 5120 | ATP5IF1/DECR1 ratio | PRORT000154 | 1.09e-05 | Protein ratios | Myeloid | 9 | 1 | 5 | 8 | |
| 5121 | TXLNA levels | PROLV002122 | 1.06e-05 | Protein levels | Platelet | 3 | 1 | 5 | 17 | |
| 5122 | BLVRB/CA3 ratio | PRORT000240 | 1.03e-05 | Protein ratios | Myeloid | 2 | 4 | 11 | 22 | |
| 5123 | KRT5 levels | PROLV001167 | 1.03e-05 | Protein levels | Cutaneous epithelium | 11 | 0 | 11 | 17 | |
| 5124 | NTN1 levels | PROLV001444 | 9.39e-06 | Protein levels | B / plasma cell | 0 | 1 | 3 | 14 | |
| 5125 | LEG1 levels | PROLV001198 | 9.06e-06 | Protein levels | Salivary epithelium | 43 | 1 | 3 | 3 | |
| 5126 | GZMA/TNFRSF8 ratio | PRORT001262 | 8.92e-06 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 5127 | Neoplasm, Skin | MALIG000034 | 8.61e-06 | Malignancy | Myeloid | 88 | 4 | 12 | 22 | |
| 5128 | FCRL5 levels | PROLV000786 | 8.56e-06 | Protein levels | B / plasma cell | 201 | 5 | 17 | 23 | |
| 5129 | ITGB1BP2/MITD1 ratio | PRORT001385 | 8.56e-06 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 5130 | CD302/IL12A_IL12B ratio | PRORT000438 | 8.45e-06 | Protein ratios | B / plasma cell | 43 | 4 | 9 | 19 | |
| 5131 | Tryptophan | METAB000030 | 8.03e-06 | Metabolites | Hepatocyte | 4 | 2 | 6 | 16 | |
| 5132 | OLR1/PLAUR ratio | PRORT001613 | 7.89e-06 | Protein ratios | Myeloid | 36 | 3 | 7 | 11 | |
| 5133 | PPIE levels | PROLV001607 | 7.74e-06 | Protein levels | Neural / glial | 0 | 1 | 7 | 9 | |
| 5134 | EDAR/ITGB1BP2 ratio | PRORT000972 | 7.74e-06 | Protein ratios | Myeloid | 49 | 5 | 17 | 20 | |
| 5135 | Sleep-related movement disorder | NEURO000016 | 7.73e-06 | Neurologic | Pancreatic epithelium | 4 | 0 | 8 | 5 | |
| 5136 | EDAR/SERPINB1 ratio | PRORT000977 | 7.60e-06 | Protein ratios | Myeloid | 29 | 2 | 8 | 14 | |
| 5137 | SLIT2 levels | PROLV001887 | 7.47e-06 | Protein levels | Neural / glial | 0 | 1 | 7 | 15 | |
| 5138 | ITGB1BP2/MED18 ratio | PRORT001384 | 7.24e-06 | Protein ratios | Muscle / cardiac | 0 | 4 | 7 | 17 | |
| 5139 | GP6/SCARF1 ratio | PRORT001234 | 7.18e-06 | Protein ratios | Myeloid | 6 | 2 | 11 | 15 | |
| 5140 | MYL3 levels | PROLV001360 | 7.08e-06 | Protein levels | Muscle / cardiac | 42 | 3 | 8 | 20 | |
| 5141 | SMPD3 levels | PROLV001902 | 7.02e-06 | Protein levels | Lymphocyte | 11 | 2 | 13 | 22 | |
| 5142 | KIF22 levels | PROLV001139 | 6.98e-06 | Protein levels | B / plasma cell | 35 | 2 | 5 | 11 | |
| 5143 | CLEC4D levels | PROLV000452 | 6.55e-06 | Protein levels | Myeloid | 21 | 1 | 5 | 13 | |
| 5144 | Physical activity, none | BEHAV000005 | 6.44e-06 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 5145 | GFRA2/IL12A_IL12B ratio | PRORT001210 | 6.38e-06 | Protein ratios | B / plasma cell | 52 | 3 | 12 | 22 | |
| 5146 | CEP43/TIA1 ratio | PRORT000601 | 6.37e-06 | Protein ratios | Myeloid | 0 | 3 | 8 | 13 | |
| 5147 | MSTN levels | PROLV001345 | 6.34e-06 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 5148 | ACY1 levels | PROLV000019 | 6.18e-06 | Protein levels | Hepatocyte | 54 | 3 | 11 | 10 | |
| 5149 | NFATC1 levels | PROLV001395 | 6.08e-06 | Protein levels | Myeloid | 34 | 2 | 6 | 12 | |
| 5150 | CRTAP levels | PROLV000531 | 6.04e-06 | Protein levels | B / plasma cell | 49 | 3 | 11 | 21 | |
| 5151 | DNM3 levels | PROLV000639 | 6.04e-06 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 10 | |
| 5152 | SLAMF7 levels | PROLV001876 | 5.93e-06 | Protein levels | Myeloid | 126 | 3 | 7 | 14 | |
| 5153 | CASP8/RILP ratio | PRORT000324 | 5.81e-06 | Protein ratios | Hepatocyte | 2 | 3 | 8 | 19 | |
| 5154 | IL12A_IL12B/LAG3 ratio | PRORT001341 | 5.75e-06 | Protein ratios | B / plasma cell | 67 | 3 | 7 | 9 | |
| 5155 | EBAG9/TBCC ratio | PRORT000962 | 5.75e-06 | Protein ratios | Muscle / cardiac | 5 | 3 | 16 | 46 | |
| 5156 | EDAR/ERBIN ratio | PRORT000967 | 5.66e-06 | Protein ratios | Myeloid | 31 | 4 | 15 | 24 | |
| 5157 | FUT8/PDGFA ratio | PRORT001187 | 5.50e-06 | Protein ratios | Hepatocyte | 8 | 2 | 15 | 50 | |
| 5158 | TMSB10/TXNRD1 ratio | PRORT001841 | 5.46e-06 | Protein ratios | Muscle / cardiac | 24 | 3 | 9 | 14 | |
| 5159 | PPP1R14D levels | PROLV001615 | 5.21e-06 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 5160 | ATOX1/TMSB10 ratio | PRORT000153 | 5.18e-06 | Protein ratios | Myeloid | 4 | 3 | 9 | 17 | |
| 5161 | OSM levels | PROLV001475 | 5.09e-06 | Protein levels | Myeloid | 82 | 3 | 10 | 22 | |
| 5162 | CEACAM21 levels | PROLV000391 | 4.80e-06 | Protein levels | Hepatocyte | 22 | 2 | 15 | 22 | |
| 5163 | LRCH4 levels | PROLV001225 | 4.69e-06 | Protein levels | Myeloid | 29 | 3 | 9 | 21 | |
| 5164 | VWC2L levels | PROLV002181 | 4.48e-06 | Protein levels | Neural / glial | 0 | 0 | 3 | 7 | |
| 5165 | ADD1 levels | PROLV000039 | 4.44e-06 | Protein levels | Lymphocyte | 1 | 1 | 9 | 31 | |
| 5166 | Heart failure, chronic | CARDI000003 | 4.38e-06 | Cardiac | Muscle / cardiac | 0 | 3 | 7 | 16 | |
| 5167 | CD4/LILRB4 ratio | PRORT000441 | 4.31e-06 | Protein ratios | Myeloid | 61 | 4 | 11 | 12 | |
| 5168 | ADAMTS15 levels | PROLV000032 | 4.24e-06 | Protein levels | Hepatocyte | 42 | 1 | 7 | 9 | |
| 5169 | FAM3B/FUT3_FUT5 ratio | PRORT001112 | 4.17e-06 | Protein ratios | Hepatocyte | 18 | 2 | 10 | 19 | |
| 5170 | KDM3A levels | PROLV001132 | 4.02e-06 | Protein levels | Lymphocyte | 21 | 2 | 16 | 40 | |
| 5171 | HPCAL1/MPIG6B ratio | PRORT001296 | 4.01e-06 | Protein ratios | Myeloid | 11 | 2 | 6 | 9 | |
| 5172 | PPM1F levels | PROLV001611 | 3.79e-06 | Protein levels | Lymphocyte | 9 | 3 | 8 | 21 | |
| 5173 | MAVS/RNF41 ratio | PRORT001499 | 3.67e-06 | Protein ratios | Muscle / cardiac | 19 | 5 | 9 | 16 | |
| 5174 | ABHD14B/SPARC ratio | PRORT000007 | 3.64e-06 | Protein ratios | Myeloid | 1 | 3 | 8 | 20 | |
| 5175 | CD79B/ICAM3 ratio | PRORT000512 | 3.48e-06 | Protein ratios | B / plasma cell | 22 | 2 | 8 | 6 | |
| 5176 | Alcoholic liver disease | HPBIL000033 | 3.47e-06 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 5177 | SCGB3A2 levels | PROLV001788 | 3.47e-06 | Protein levels | Respiratory epithelium | 35 | 2 | 9 | 16 | |
| 5178 | TRIM5 levels | PROLV002110 | 3.43e-06 | Protein levels | Hepatocyte | 9 | 2 | 12 | 30 | |
| 5179 | Hashimoto thyroiditis | IMMUN000028 | 3.43e-06 | Immunologic | Neural / glial | — | 2 | 4 | 8 | |
| 5180 | CD27/TNFRSF13B ratio | PRORT000418 | 3.38e-06 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 5181 | DDC levels | PROLV000608 | 3.29e-06 | Protein levels | Hepatocyte | 76 | 2 | 7 | 14 | |
| 5182 | GSTA1/KRT18 ratio | PRORT001249 | 3.20e-06 | Protein ratios | Hepatocyte | 13 | 2 | 7 | 12 | |
| 5183 | FABP1/FABP2 ratio | PRORT001094 | 3.09e-06 | Protein ratios | Hepatocyte | 10 | 2 | 6 | 16 | |
| 5184 | CD27/FCRL5 ratio | PRORT000413 | 3.06e-06 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 5185 | FIS1/PDGFB ratio | PRORT001150 | 3.03e-06 | Protein ratios | Myeloid | 14 | 2 | 8 | 23 | |
| 5186 | Medication, proton pump inhibitor | GASTR000017 | 2.96e-06 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 5187 | XPNPEP2 levels | PROLV002199 | 2.94e-06 | Protein levels | Hepatocyte | 67 | 2 | 9 | 14 | |
| 5188 | KLRD1/LY9 ratio | PRORT001415 | 2.88e-06 | Protein ratios | Myeloid | 57 | 3 | 13 | 23 | |
| 5189 | MGAT2 levels | PROLV001308 | 2.70e-06 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 5190 | PDE5A levels | PROLV001520 | 2.62e-06 | Protein levels | Muscle / cardiac | 19 | 2 | 8 | 18 | |
| 5191 | Latent factor, neutrophil and lymphocyte | HEMAT000035 | 2.61e-06 | Hematologic | Myeloid | 675 | 4 | 18 | 31 | |
| 5192 | LRP11/ROR1 ratio | PRORT001461 | 2.57e-06 | Protein ratios | Vascular | 0 | 0 | 4 | 10 | |
| 5193 | F2R/TNFRSF14 ratio | PRORT001085 | 2.55e-06 | Protein ratios | Lymphocyte | 15 | 3 | 9 | 34 | |
| 5194 | IL19 levels | PROLV001058 | 2.34e-06 | Protein levels | Vascular | 20 | 0 | 7 | 23 | |
| 5195 | LRRC37A2 levels | PROLV001233 | 2.34e-06 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 5196 | RSPO1/RSPO3 ratio | PRORT001750 | 2.27e-06 | Protein ratios | Myeloid | 5 | 4 | 6 | 14 | |
| 5197 | Fall risk | MSKEL000043 | 2.20e-06 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 5198 | CDH3/NECTIN4 ratio | PRORT000554 | 2.11e-06 | Protein ratios | Respiratory epithelium | 19 | 0 | 10 | 9 | |
| 5199 | Free thyroxine | ENDOC000018 | 2.09e-06 | Endocrine | Hepatocyte | 8 | 3 | 9 | 12 | |
| 5200 | INHBB levels | PROLV001087 | 2.05e-06 | Protein levels | Hepatocyte | 38 | 6 | 10 | 14 | |
| 5201 | GIMAP7 levels | PROLV000887 | 2.01e-06 | Protein levels | Lymphocyte | 26 | 2 | 10 | 41 | |
| 5202 | FGFBP3 levels | PROLV000800 | 1.99e-06 | Protein levels | Myeloid | 16 | 5 | 13 | 15 | |
| 5203 | Skin eruption | DERMA000027 | 1.96e-06 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 5204 | Thyroid peroxidase antibodies | IMMUN000045 | 1.67e-06 | Immunologic | Lymphocyte | 20 | 2 | 14 | 22 | |
| 5205 | GABBR2 levels | PROLV000845 | 1.64e-06 | Protein levels | B / plasma cell | 0 | 2 | 4 | 9 | |
| 5206 | CCL5/SELP ratio | PRORT000358 | 1.60e-06 | Protein ratios | Lymphocyte | 2 | 1 | 6 | 32 | |
| 5207 | F2R/PDGFB ratio | PRORT001079 | 1.50e-06 | Protein ratios | Myeloid | 16 | 4 | 9 | 15 | |
| 5208 | NFATC1/SPRY2 ratio | PRORT001586 | 1.48e-06 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 32 | |
| 5209 | ZP3 levels | PROLV002215 | 1.45e-06 | Protein levels | B / plasma cell | 28 | 1 | 6 | 17 | |
| 5210 | CEACAM16 levels | PROLV000388 | 1.43e-06 | Protein levels | Hepatocyte | 128 | 1 | 7 | 11 | |
| 5211 | PF4 levels | PROLV001538 | 1.28e-06 | Protein levels | Myeloid | 34 | 4 | 9 | 18 | |
| 5212 | Pregnancy complication, preterm labour | REPRO000034 | 1.16e-06 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 5213 | DBNL/PDGFB ratio | PRORT000868 | 1.09e-06 | Protein ratios | Myeloid | 35 | 4 | 13 | 18 | |
| 5214 | PCOLCE levels | PROLV001510 | 1.06e-06 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 5215 | LY6D/NECTIN4 ratio | PRORT001468 | 1.05e-06 | Protein ratios | Cutaneous epithelium | 13 | 0 | 8 | 11 | |
| 5216 | FGF2/HBEGF ratio | PRORT001140 | 1.02e-06 | Protein ratios | Myeloid | 42 | 2 | 8 | 12 | |
| 5217 | Medication use | MISCL000037 | 9.92e-07 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 5218 | Oestrogen metabolite | ENDOC000009 | 9.41e-07 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 5219 | KRT18 levels | PROLV001165 | 9.14e-07 | Protein levels | Hepatocyte | 62 | 1 | 9 | 29 | |
| 5220 | Gut microbial abundance, Chromatiales | GASTR000024 | 9.06e-07 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 5221 | DLL1/NOTCH1 ratio | PRORT000918 | 8.80e-07 | Protein ratios | Vascular | 8 | 0 | 6 | 11 | |
| 5222 | Hypothyroidism, acquired | ENDOC000012 | 8.61e-07 | Endocrine | Hepatocyte | 1 | 4 | 11 | 37 | |
| 5223 | DAB2/NCK2 ratio | PRORT000840 | 8.22e-07 | Protein ratios | Myeloid | 2 | 3 | 9 | 13 | |
| 5224 | CD27/ICAM3 ratio | PRORT000414 | 7.87e-07 | Protein ratios | B / plasma cell | 33 | 0 | 4 | 7 | |
| 5225 | CDH2/SSC4D ratio | PRORT000553 | 7.37e-07 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 14 | |
| 5226 | CD48/FCRL6 ratio | PRORT000464 | 7.35e-07 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 5227 | PPBP levels | PROLV001604 | 7.29e-07 | Protein levels | Neural / glial | 68 | 3 | 9 | 15 | |
| 5228 | CHMP1A/RHOC ratio | PRORT000613 | 6.84e-07 | Protein ratios | Myeloid | 18 | 3 | 13 | 19 | |
| 5229 | ITGB1BP2/SKAP2 ratio | PRORT001387 | 6.48e-07 | Protein ratios | Lymphocyte | 14 | 4 | 8 | 35 | |
| 5230 | ICAM3/NOTCH1 ratio | PRORT001327 | 6.37e-07 | Protein ratios | Hepatocyte | 22 | 2 | 9 | 23 | |
| 5231 | TPSAB1 levels | PROLV002099 | 6.23e-07 | Protein levels | Lymphocyte | 33 | 2 | 14 | 25 | |
| 5232 | Diabetes, secondary | METBL000032 | 6.22e-07 | Metabolic | Neural / glial | 0 | 2 | 10 | 24 | |
| 5233 | ATP5IF1/METAP1D ratio | PRORT000160 | 5.31e-07 | Protein ratios | Myeloid | 6 | 3 | 9 | 28 | |
| 5234 | CXCL11/DKK1 ratio | PRORT000817 | 5.28e-07 | Protein ratios | Myeloid | 13 | 4 | 15 | 21 | |
| 5235 | AGR3 levels | PROLV000056 | 5.16e-07 | Protein levels | Myeloid | 11 | 1 | 7 | 10 | |
| 5236 | CSF2 levels | PROLV000538 | 5.06e-07 | Protein levels | Muscle / cardiac | 12 | 1 | 2 | 21 | |
| 5237 | DOK2/PPP1R12A ratio | PRORT000941 | 4.96e-07 | Protein ratios | Hepatocyte | 9 | 4 | 11 | 17 | |
| 5238 | RAB31 levels | PROLV001699 | 4.74e-07 | Protein levels | Lymphocyte | 0 | 3 | 6 | 14 | |
| 5239 | EDAR/IPCEF1 ratio | PRORT000970 | 4.52e-07 | Protein ratios | Myeloid | 32 | 3 | 15 | 18 | |
| 5240 | AK1 levels | PROLV000070 | 4.20e-07 | Protein levels | B / plasma cell | 0 | 3 | 15 | 48 | |
| 5241 | FOLR3/KLK8 ratio | PRORT001171 | 4.12e-07 | Protein ratios | Myeloid | 24 | 2 | 10 | 15 | |
| 5242 | PDGFB/USP8 ratio | PRORT001650 | 3.92e-07 | Protein ratios | Myeloid | 7 | 3 | 13 | 24 | |
| 5243 | CASP3/SERPINE1 ratio | PRORT000319 | 3.52e-07 | Protein ratios | Muscle / cardiac | 0 | 3 | 14 | 20 | |
| 5244 | CSF3 levels | PROLV000540 | 3.30e-07 | Protein levels | Myeloid | 40 | 2 | 7 | 9 | |
| 5245 | MAVS/MED18 ratio | PRORT001495 | 3.20e-07 | Protein ratios | Lymphocyte | 20 | 6 | 15 | 39 | |
| 5246 | MAPRE3 levels | PROLV001273 | 3.19e-07 | Protein levels | Lymphocyte | 67 | 3 | 16 | 32 | |
| 5247 | DSC2/SPINT1 ratio | PRORT000951 | 3.17e-07 | Protein ratios | Epithelial | 23 | 0 | 7 | 3 | |
| 5248 | GDF15 levels | PROLV000869 | 2.80e-07 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 5249 | FCRL5/ICAM3 ratio | PRORT001133 | 2.48e-07 | Protein ratios | B / plasma cell | 52 | 4 | 21 | 31 | |
| 5250 | NPTX1 levels | PROLV001426 | 2.10e-07 | Protein levels | Platelet | 78 | 3 | 7 | 10 | |
| 5251 | HEXIM1/NT5C3A ratio | PRORT001278 | 2.09e-07 | Protein ratios | Hepatocyte | 17 | 4 | 10 | 20 | |
| 5252 | Immunoglobulin deficiency | IMMUN000049 | 1.71e-07 | Immunologic | B / plasma cell | 4 | 2 | 3 | 11 | |
| 5253 | COVID-19 | IMMUN000054 | 1.56e-07 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 5254 | FCRL6/GZMA ratio | PRORT001137 | 1.54e-07 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 5255 | EDIL3 levels | PROLV000675 | 1.40e-07 | Protein levels | Lymphocyte | 4 | 2 | 10 | 30 | |
| 5256 | ENO2/PLXNA4 ratio | PRORT001027 | 1.27e-07 | Protein ratios | Myeloid | 5 | 4 | 13 | 39 | |
| 5257 | KLRF1 levels | PROLV001163 | 1.18e-07 | Protein levels | Lymphocyte | 134 | 3 | 14 | 15 | |
| 5258 | A4GALT levels | PROLV000002 | 1.15e-07 | Protein levels | Vascular | 7 | 0 | 2 | 1 | |
| 5259 | SNAP23/TXLNA ratio | PRORT001795 | 1.07e-07 | Protein ratios | Hepatocyte | 0 | 2 | 12 | 24 | |
| 5260 | LGALS4/PCDH17 ratio | PRORT001450 | 1.00e-07 | Protein ratios | B / plasma cell | 4 | 2 | 6 | 10 | |
| 5261 | PBXIP1 levels | PROLV001501 | 7.72e-08 | Protein levels | Myeloid | 23 | 2 | 6 | 12 | |
| 5262 | DTX3 levels | PROLV000660 | 7.38e-08 | Protein levels | Renal epithelium | 2 | 0 | 3 | 9 | |
| 5263 | TGFBR2/TNFRSF1A ratio | PRORT001835 | 5.91e-08 | Protein ratios | Neural / glial | 23 | 1 | 8 | 13 | |
| 5264 | IPCEF1/SPARC ratio | PRORT001363 | 5.54e-08 | Protein ratios | Myeloid | 11 | 3 | 18 | 31 | |
| 5265 | ADH4/KRT18 ratio | PRORT000040 | 4.20e-08 | Protein ratios | Hepatocyte | 12 | 1 | 11 | 17 | |
| 5266 | LACRT levels | PROLV001173 | 4.13e-08 | Protein levels | Cutaneous epithelium | 32 | 1 | 8 | 13 | |
| 5267 | COL6A3/SPON2 ratio | PRORT000701 | 3.87e-08 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 5268 | ADAMTS8/FAP ratio | PRORT000026 | 3.21e-08 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 5269 | PDGFA/SCARF1 ratio | PRORT001634 | 1.95e-08 | Protein ratios | Myeloid | 34 | 3 | 9 | 14 | |
| 5270 | CD160/CXCL16 ratio | PRORT000376 | 1.93e-08 | Protein ratios | Lymphocyte | 12 | 2 | 13 | 32 | |
| 5271 | F2R/SERPINE1 ratio | PRORT001081 | 1.78e-08 | Protein ratios | Myeloid | 15 | 3 | 12 | 20 | |
| 5272 | CD244/FCRL6 ratio | PRORT000408 | 1.45e-08 | Protein ratios | Lymphocyte | 9 | 2 | 12 | 33 | |
| 5273 | Hypercalcaemia | METBL000005 | 1.38e-08 | Metabolic | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 5274 | RPN1 levels | PROLV001754 | 1.29e-08 | Protein levels | Hepatocyte | 2 | 3 | 8 | 15 | |
| 5275 | VEGFB levels | PROLV002158 | 8.86e-09 | Protein levels | Lymphocyte | 54 | 3 | 14 | 35 | |
| 5276 | SSC4D/TNFSF10 ratio | PRORT001816 | 8.09e-09 | Protein ratios | Hepatocyte | 11 | 2 | 7 | 14 | |
| 5277 | ICAM3/LY9 ratio | PRORT001326 | 6.33e-09 | Protein ratios | B / plasma cell | 36 | 3 | 13 | 42 | |
| 5278 | GNS levels | PROLV000907 | 6.09e-09 | Protein levels | Myeloid | 0 | 1 | 7 | 13 | |
| 5279 | ALCAM/ENPP2 ratio | PRORT000070 | 4.80e-09 | Protein ratios | Hepatocyte | 51 | 3 | 12 | 18 | |
| 5280 | DSG3/NECTIN4 ratio | PRORT000954 | 4.43e-09 | Protein ratios | Lymphocyte | 35 | 0 | 15 | 27 | |
| 5281 | GZMA/TNFRSF4 ratio | PRORT001261 | 2.91e-09 | Protein ratios | Lymphocyte | 36 | 3 | 15 | 35 | |
| 5282 | CD69/PLXNA4 ratio | PRORT000494 | 2.33e-09 | Protein ratios | Myeloid | 29 | 3 | 6 | 18 | |
| 5283 | NPDC1/TAFA5 ratio | PRORT001595 | 1.10e-09 | Protein ratios | Vascular | 24 | 4 | 9 | 29 | |
| 5284 | BSG/LY9 ratio | PRORT000249 | 6.85e-10 | Protein ratios | B / plasma cell | 12 | 1 | 6 | 19 | |
| 5285 | PDGFA/USP8 ratio | PRORT001638 | 5.96e-10 | Protein ratios | Myeloid | 3 | 4 | 16 | 26 | |
| 5286 | IL10 levels | PROLV001042 | 5.90e-10 | Protein levels | Lymphocyte | 50 | 1 | 13 | 25 | |
| 5287 | DKK1/PPCDC ratio | PRORT000899 | 4.21e-10 | Protein ratios | Myeloid | 14 | 2 | 10 | 16 | |
| 5288 | CIAPIN1/VEGFC ratio | PRORT000619 | 8.55e-11 | Protein ratios | Platelet | 3 | 2 | 9 | 30 |